Analysis of the Infinium Human Methylation 450K BeadChip assay data from TCGA revealed that CCND2 promoter hypermethylation was more frequently aberrant in breast cancer, lung adenocarcinoma, and liver cancer than in adjacent normal tissues (Figure 2). This evidence concerns the gene CCND2 and lung adenocarcinoma.